Category Industry Updates

PANCAID Consortium Selects biomodal’s duet 6-Base Mosaic Technology to Advance Early Pancreatic Cancer Detection

PANCAID Consortium Selects biomodal’s duet 6-base mosaic Technology to Support Early Detection of Pancreatic Cancer biomodal, an omics-based life sciences technology and analytics company, has announced that PANCAID (PANcreatic CAncer Initial Detection via liquid biopsy), a pan-European research consortium comprising…

Read MorePANCAID Consortium Selects biomodal’s duet 6-Base Mosaic Technology to Advance Early Pancreatic Cancer Detection

Mosaic Reporting™ Surpasses 100,000 Radiology Reports Processed Daily

Mosaic Clinical Technologies Surpasses 100,000 Daily Radiology Reports with AI-Assisted Mosaic Reporting Platform Mosaic Clinical Technologies, a healthcare technology company focused on improving radiology reporting workflows, has announced that radiologists using its Mosaic Reporting application are now completing more than…

Read MoreMosaic Reporting™ Surpasses 100,000 Radiology Reports Processed Daily

Journal of Independent Medicine Publishes New Issue Highlighting Global Scientific Perspectives

Independent Medical Alliance Publishes Volume 2, No. 5 of Journal of Independent Medicine, Expanding Global Scientific Collaboration The Independent Medical Alliance (IMA) has announced the publication of Volume 2, No. 5 of the Journal of Independent Medicine (JIM), marking another…

Read MoreJournal of Independent Medicine Publishes New Issue Highlighting Global Scientific Perspectives

Aphena Pharma Solutions Implements QAD Adaptive ERP, Establishing a Modern Foundation for Enterprise Operations

Aphena Pharma Solutions Goes Live on QAD Adaptive ERP, Modernizing Pharmaceutical Manufacturing and Business Operations Aphena Pharma Solutions, a leading U.S.-based pharmaceutical contract manufacturing and packaging organization, has successfully gone live on QAD Adaptive ERP, marking an important milestone in…

Read MoreAphena Pharma Solutions Implements QAD Adaptive ERP, Establishing a Modern Foundation for Enterprise Operations

Northwell’s Feinstein Institutes’ Dr. Kevin J. Tracey Honored with Cold Spring Harbor Laboratory Double Helix Medal

Kevin J. Tracey Receives Prestigious Double Helix Medal for Pioneering Contributions to Bioelectronic Medicine Kevin J. Tracey, MD, widely recognized as the founding father of bioelectronic medicine and president and chief executive officer of Northwell Health’s Feinstein Institutes for Medical…

Read MoreNorthwell’s Feinstein Institutes’ Dr. Kevin J. Tracey Honored with Cold Spring Harbor Laboratory Double Helix Medal

Lilly Begins Construction of $3.5 Billion Pennsylvania Manufacturing Site to Expand Production of Next-Generation Obesity Medicines

Eli Lilly Breaks Ground on $3.5 Billion Lehigh Valley Manufacturing Facility to Expand Production of Next-Generation Obesity Medicines Eli Lilly and Company has officially broken ground on a new $3.5 billion pharmaceutical manufacturing facility in Pennsylvania’s Lehigh Valley, marking another…

Read MoreLilly Begins Construction of $3.5 Billion Pennsylvania Manufacturing Site to Expand Production of Next-Generation Obesity Medicines

Palleon Pharmaceuticals Reports Phase 2 Results of HLX79/E-602 in Primary Membranous Nephropathy at ACR Convergence 2026

Palleon Pharmaceuticals Reports Early Proof-of-Concept Results for HLX79/E-602 in Primary Membranous Nephropathy Palleon Pharmaceuticals, a clinical-stage biotechnology company developing innovative glycan-editing therapeutics for autoimmune diseases and cancer, has announced encouraging early proof-of-concept results from a Phase 2 clinical trial evaluating…

Read MorePalleon Pharmaceuticals Reports Phase 2 Results of HLX79/E-602 in Primary Membranous Nephropathy at ACR Convergence 2026

AstraZeneca Awards $1.6 Million to Expand Healthcare Access for Patients Across the United States

AstraZeneca Awards $1.6 Million in Grants to 55 Nonprofits Through 2026 Community Solutions Challenge to Advance Health Equity AstraZeneca has announced $1.6 million in grant funding for nonprofit organizations across the United States through its Accelerate Change Together (ACT) on…

Read MoreAstraZeneca Awards $1.6 Million to Expand Healthcare Access for Patients Across the United States

CareQuest and Henry Schein Launch BRIDGE Health Network to Strengthen Dental-Medical Integration

CareQuest Institute and Henry Schein Launch BRIDGE Health Network to Advance Dental-Medical Integration and Preventive Healthcare CareQuest Institute for Oral Health and Henry Schein, Inc. have announced the launch of the BRIDGE Health Network, a collaborative initiative designed to strengthen…

Read MoreCareQuest and Henry Schein Launch BRIDGE Health Network to Strengthen Dental-Medical Integration

Obsidian Therapeutics to Present Updated Amsoki-cel Clinical Data in Advanced Melanoma at SITC 2026

Obsidian Therapeutics Reports Promising Amsoki-Cel Results in ICI-Resistant Advanced Melanoma, With 67% Response Rate Obsidian Therapeutics, a clinical-stage biopharmaceutical company developing engineered tumor-infiltrating lymphocyte (TIL) cell therapies through its proprietary protein-regulation technology, has announced positive updated clinical results for amsokigene…

Read MoreObsidian Therapeutics to Present Updated Amsoki-cel Clinical Data in Advanced Melanoma at SITC 2026

Pulse Biosciences Reports Six-Month PRECISE-BTN Study Results at ATA Annual Meeting

Pulse Biosciences Reports Encouraging Six-Month PRECISE-BTN Study Results for nPulse Vybrance System in Benign Thyroid Nodules Pulse Biosciences, Inc., a medical technology company developing its proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, has announced encouraging interim six-month clinical…

Read MorePulse Biosciences Reports Six-Month PRECISE-BTN Study Results at ATA Annual Meeting